Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comorbidity in Adult Psoriasis: Considerations for the Clinician
Christine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 139-150
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice
Ahmed Wahhab Mohammed Khafaji, Adeeb Ahmed Kadhim Al-Zubaidy, Iqbal Farhood, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6231-6248
Closed Access | Times Cited: 15
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis
H. Salman, Elaf Mahmood Shihab, Hasanain Hasan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 9, pp. 2739-2754
Open Access | Times Cited: 15
The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation
H. Salman, Adeeb A. Al-Zubaidy, Alaa Hamza Abbas, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 12
Etiopathogenesis of Psoriasis: Integration of Proposed Theories
Brenda Fernanda Hernandez-Nicols, Juan José Robledo-Pulido, Anabell Alvarado‐Navarro
Immunological Investigations (2024) Vol. 53, Iss. 3, pp. 348-415
Closed Access | Times Cited: 9
Psychological Well-Being of Adult Psoriasis Patients: A Narrative Review
Ankita Hepat, Swarupa Chakole, Asmita Rannaware
Cureus (2023)
Open Access | Times Cited: 16
The anti‐inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: Prenylation and methoxylation beneficially enhance bioactivity and skin targeting
Chwan‐Fwu Lin, Ming‐Hsien Lin, Chi‐Feng Hung, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1951-1970
Closed Access | Times Cited: 7
The long-term impact of bariatric surgery on psoriasis symptoms and severity: a prospective observational study
Ali Hosseininasab, Hesam Mosavari, Aghil Rostami, et al.
Surgery for Obesity and Related Diseases (2024) Vol. 20, Iss. 12, pp. 1208-1213
Closed Access | Times Cited: 5
IL-1 signaling enrichment in inflammatory skin disease loci with higher risk allele frequencies in African ancestry
Lam C. Tsoi, Yumeng Dong, Matthew T. Patrick, et al.
Research Square (Research Square) (2025)
Closed Access
Biologics and skin cancer risk in psoriasis patients
Christopher A Guirguis, Lauren Ching, Laura K. Ferris
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Single-cell RNA sequencing of circulating immune cells supports inhibition of TNFAIP3 and NFKBIA translation as psoriatic arthritis biomarkers
Alícia Garrido, Rohan Machhar, Omar Fernando Cruz-Correa, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs
Li Tian Keane Teo, Nerissa Juantuah-Kusi, Gowtham Subramanian, et al.
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 16-16
Open Access
Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: Beyond drug carriers
Wang‐Hee Lee, Wook Kim
Journal of Controlled Release (2023) Vol. 366, pp. 114-127
Closed Access | Times Cited: 10
The role of adipokines in the pathogenesis of psoriasis – a focus on resistin, omentin-1 and vaspin
Kajetan Kiełbowski, Estera Bakinowska, Aleksandra Wiktoria Bratborska, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 587-600
Closed Access | Times Cited: 2
Happiness across the borders—A cross‐sectional study among patients with psoriasis and atopic dermatitis in Europe
Stefanie Ziehfreund, Hannah Wecker, Sonja Mittag, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 2
Assessment of soluble skin surface protein levels for monitoring psoriasis vulgaris in adult psoriasis patients using non-invasive transdermal analysis patch: A pilot study
Kadri Orro, Kristiina Salk, Kristi Abram, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Psoriasis and exposome: Unveiling the inner and the external contributors of psoriasis disease
Efterpi Zafiriou, Emmanouil Karampinis, Angeliki-Victoria Roussaki-Schulze
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program
Hyemin Jung, Seong Rae Kim, Soo Ick Cho, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients’ Personal Experiences and Perspectives
Kasper Fjellhaugen Hjuler, Louise Møller, Cathrine Dawn Büttner Elgaard, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 2635-2646
Open Access | Times Cited: 1
From Manifestations to Innovations: A Deep Dive into Psoriasis, its Clinical Diversity, Conventional Treatments, and Emerging Therapeutic Paradigms
Sneha Garg, Muskan Dixit, Iresha Malhotra, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113508-113508
Closed Access | Times Cited: 1
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression
Maria-Lorena Mustață, Mihaela Ionescu, Lucreţiu Radu, et al.
Diagnostics (2024) Vol. 14, Iss. 24, pp. 2887-2887
Open Access | Times Cited: 1
Does biological agent treatment have an impact on serum uric acid levels in patients with psoriasis?
Funda Tamer, Yusuf Can Edek, A. Burhan Aksakal
Current Medical Research and Opinion (2023) Vol. 39, Iss. 10, pp. 1297-1302
Closed Access | Times Cited: 3
The Steatosis-Associated Fibrosis Estimator (SAFE) score for assessing significant liver fibrosis in patients with psoriasis
Leena Chularojanamontri, Waratchaya Panjapakkul, Teerapat Paringkarn, et al.
Clinical and Experimental Dermatology (2023) Vol. 49, Iss. 4, pp. 337-343
Closed Access | Times Cited: 2
Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy
Kadri Orro, Kristiina Salk, Anna V. Merkulova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16248-16248
Open Access | Times Cited: 2
The effect of hypertension on the course and severity of psoriasis
M. T. Muminova, О. В. Жукова, E. V. Dvoryankova, et al.
Vrach (2023) Vol. 34, Iss. 4, pp. 86-88
Closed Access | Times Cited: 2
Comorbidity structure in psoriasis patients according to dermatology department data
E. A. Trapeznikova, A. I. Yakubovich, E. G. Gaydarova
Pacific Medical Journal (2024), Iss. 2, pp. 33-36
Open Access
Page 1 - Next Page

Scroll to top